Cart
sales@molnova.com
L-GLUCOSE
CAS No. 921-60-8
L-GLUCOSE( L-(-)-Glucose )
Catalog No. M19912 CAS No. 921-60-8
L-Glucose is an enantiomer of D-glucose. L-Glucose is not bioavailable to cells as an energy source because it cannot be phosphorylated by hexokinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameL-GLUCOSE
-
NoteResearch use only, not for human use.
-
Brief DescriptionL-Glucose is an enantiomer of D-glucose. L-Glucose is not bioavailable to cells as an energy source because it cannot be phosphorylated by hexokinase.
-
DescriptionL-Glucose is an enantiomer of D-glucose. L-Glucose is not bioavailable to cells as an energy source because it cannot be phosphorylated by hexokinase.
-
In Vitro——
-
In Vivo——
-
SynonymsL-(-)-Glucose
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number921-60-8
-
Formula Weight180.16
-
Molecular FormulaC6H12O6
-
Purity>98% (HPLC)
-
SolubilityDMSO: 30 mg/mL;Water: 50 mg/mL
-
SMILESOC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@H]1O
-
Chemical Name(3S4R5R6S)-6-(hydroxymethyl)tetrahydro-2H-pyran-2345-tetraol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shimizu T et al. An L-glucose catabolic pathway in Paracoccus species 43P. J Biol Chem. 2012 Nov 23;287(48):40448-56.
molnova catalog
related products
-
Ethyl oleate
Ethyl oleate is the liquid lipid component in nanostructured lipid carriers (NLCs).?NLC is a promising vehicle for oral trans-Ferulic acid (TFA) administration.?
-
Peroxydehydrotumulos...
5alpha,8alpha-Peroxydehydrotumulosic acid exhibits inhibitory effects against the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells.
-
EZH2-IN-15
EZH2-IN-15 (SHR2554) is a specific inhibitor of the zeste 2 histone modification enhancer (EZH2).EZH2 is aberrantly overexpressed in many human cancers and controls adaptive responses by regulating Treg activity.
